Mylan will refund 340B covered entities a total of $19.3 million for overcharges on the EpiPen as part of its recent settlement agreement with the
The OPA 340B database will be unavailable from August 15, 2017 through mid-September 2017 as HRSA transitions to a new database system. During this time,
The Government Accountability Office (GAO) submitted a report on 340B program oversight as part of its testimony during the House Energy and Commerce’s Subcommittee on
Here is a copy of the materials that the Alliance for Integrity and Reform of 340B (AIR-340B) shared with attendees at its Hill briefing on
